Stimulation of suicidal erythrocyte death by ribavirin

Basic and Clinical Pharmacology and Toxicology

Volumn 114, Issue 4, 2014, Pages 311-317

  Oswald, Gergely ^a   Alzoubi, Kousi ^a   Abed, Majed ^a   Lang, Florian ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; FLUO 3; HEMOGLOBIN; LIPOCORTIN 5; PHOSPHATIDYLSERINE; RIBAVIRIN;

ARTICLE; BINDING AFFINITY; CELL DEATH; CELL STIMULATION; CELL VOLUME; CONTROLLED STUDY; DRUG EXPOSURE; ERYTHROCYTE; ERYTHROCYTE MEMBRANE; ERYTHROCYTE VOLUME; ERYTHROPOIESIS; EXTRACELLULAR CALCIUM; FLUORESCENCE; HEMOLYSIS; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SUICIDAL ERYTHROCYTE DEATH; SUICIDE;

CALCIUM; CELL DEATH; CELL MEMBRANE; CELL SIZE; CELLS, CULTURED; CYTOSOL; ERYTHROCYTES; HEMOLYSIS; HUMANS; PHOSPHATIDYLSERINES; RIBAVIRIN;

EID: 84895436308     PISSN: 17427835     EISSN: 17427843     Source Type: Journal    
DOI: 10.1111/bcpt.12165     Document Type: Article

References (100)

1. Gara N, Ghany MG. What the infectious disease physician needs to know about pegylated interferon and ribavirin. Clin Infect Dis 2013;56:1629-36.
2. Anatol P, Danuta P, Janusz D, Bozena P. Expression of bcl-2 protein in chronic hepatitis C: effect of interferon alpha 2b with ribavirin therapy. World J Gastroenterol 2005;11:2949-52.
3. Anatol P, Robert F, Danuta P. Effect of interferon alpha2b plus ribavirin treatment on selected growth factors in respect to inflammation and fibrosis in chronic hepatitis C. World J Gastroenterol 2005;11:1854-8.
4. Di Bisceglie AM, Conjeevaram HS, Fried MW, Sallie R, Park Y, Yurdaydin C et al. Ribavirin as therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 1995;123:897-903.
5. Jablonowska E, Wojcik K, Kur B, Lewkowicz P, Nocun M. Neutrophil function and apoptosis in patients with chronic hepatitis C treated with pegylated interferon alpha and ribavirin. Arch Immunol Ther Exp (Warsz) 2012;60:61-8.
6. Jablonowska E, Wojcik K, Nocun M. The influence of treatment with pegylated interferon-alfa and ribavirin on neutrophil function and death in patients with HIV/HCV coinfection. Viral Immunol 2012;25:166-72.
7. Lai MY, Kao JH, Yang PM, Wang JT, Chen PJ, Chan KW et al. Long-term efficacy of ribavirin plus interferon alfa in the treatment of chronic hepatitis C. Gastroenterology 1996;111:1307-12.
8. Lee S, Hammond T, Watson MW, Flexman JP, Cheng W, Fernandez S et al. Could a loss of memory T cells limit responses to hepatitis C virus (HCV) antigens in blood leucocytes from patients chronically infected with HCV before and during pegylated interferon-alpha and ribavirin therapy? Clin Exp Immunol 2010;161:118-26.
9. Marin-Serrano E, Rodriguez-Ramos C, Diaz F, Martin-Herrera L, Giron-Gonzalez JA. Modulation of the anti-inflammatory interleukin 10 and of proapoptotic IL-18 in patients with chronic hepatitis C treated with interferon alpha and ribavirin. J Viral Hepat 2006;13:230-4.
10. Meier V, Burger E, Mihm S, Saile B, Ramadori G. Ribavirin inhibits DNA, RNA, and protein synthesis in PHA-stimulated human peripheral blood mononuclear cells: possible explanation for therapeutic efficacy in patients with chronic HCV infection. J Med Virol 2003;69:50-8.
11. Thomas E, Ghany MG, Liang TJ. The application and mechanism of action of ribavirin in therapy of hepatitis C. Antivir Chem Chemother 2012;23:1-12.
12. Feld JJ, Hoofnagle JH. Mechanism of action of interferon and ribavirin in treatment of hepatitis C. Nature 2005;436:967-72.
13. Lau JY, Tam RC, Liang TJ, Hong Z. Mechanism of action of ribavirin in the combination treatment of chronic HCV infection. Hepatology 2002;35:1002-9.
14. Lutchman G, Danehower S, Song BC, Liang TJ, Hoofnagle JH, Thomson M et al. Mutation rate of the hepatitis C virus NS5B in patients undergoing treatment with ribavirin monotherapy. Gastroenterology 2007;132:1757-66.
15. Barnes E, Salio M, Cerundolo V, Medlin J, Murphy S, Dusheiko G et al. Impact of alpha interferon and ribavirin on the function of maturing dendritic cells. Antimicrob Agents Chemother 2004;48:3382-9.
16. Thomas E, Feld JJ, Li Q, Hu Z, Fried MW, Liang TJ. Ribavirin potentiates interferon action by augmenting interferon-stimulated gene induction in hepatitis C virus cell culture models. Hepatology 2011;53:32-41.
17. Kokeny S, Papp J, Weber G, Vaszko T, Carmona-Saez P, Olah E. Ribavirin acts via multiple pathways in inhibition of leukemic cell proliferation. Anticancer Res 2009;29:1971-80.
18. Schiavon LL, Narciso-Schiavon JL, Carvalho-Filho RJ, Sampaio JP, El Batah PN, Silva GA et al. Evidence of a significant role for Fas-mediated apoptosis in HCV clearance during pegylated interferon plus ribavirin combination therapy. Antivir Ther 2011;16:291-8.
19. Schlosser SF, Schuler M, Berg CP, Lauber K, Schulze-Osthoff K, Schmahl FW et al. Ribavirin and alpha interferon enhance death receptor-mediated apoptosis and caspase activation in human hepatoma cells. Antimicrob Agents Chemother 2003;47:1912-21.
20. Tan K, Culjkovic B, Amri A, Borden KL. Ribavirin targets eIF4E dependent Akt survival signaling. Biochem Biophys Res Commun 2008;375:341-5.
21. De Franceschi L, Fattovich G, Turrini F, Ayi K, Brugnara C, Manzato F et al. Hemolytic anemia induced by ribavirin therapy in patients with chronic hepatitis C virus infection: role of membrane oxidative damage. Hepatology 2000;31:997-1004.
22. Lang F, Gulbins E, Lerche H, Huber SM, Kempe DS, Fller M. Eryptosis, a window to systemic disease. Cell Physiol Biochem 2008;22:373-80.
23. Lang PA, Kaiser S, Myssina S, Birka C, Weinstock C, Northoff H et al. Effect of Vibrio parahaemolyticus haemolysin on human erythrocytes. Cell Microbiol 2004;6:391-400.
24. Lang PA, Beringer O, Nicolay JP, Amon O, Kempe DS, Hermle T et al. Suicidal death of erythrocytes in recurrent hemolytic uremic syndrome. J Mol Med (Berl) 2006;84:378-88.
25. Foller M, Kasinathan RS, Koka S, Lang C, Shumilina E, Birnbaumer L et al. TRPC6 contributes to the Ca(2+) leak of human erythrocytes. Cell Physiol Biochem 2008;21:183-92.
26. Foller M, Sopjani M, Koka S, Gu S, Mahmud H, Wang K et al. Regulation of erythrocyte survival by AMP-activated protein kinase. FASEB J 2009;23:1072-80.
27. Brugnara C, de Franceschi L, Alper SL. Inhibition of Ca(2+)-dependent K+ transport and cell dehydration in sickle erythrocytes by clotrimazole and other imidazole derivatives. J Clin Invest 1993;92:520-6.
28. Lang PA, Kaiser S, Myssina S, Wieder T, Lang F, Huber SM. Role of Ca2+-activated K+ channels in human erythrocyte apoptosis. Am J Physiol Cell Physiol 2003;285:C1553-60.
29. Berg CP, Engels IH, Rothbart A, Lauber K, Renz A, Schlosser SF et al. Human mature red blood cells express caspase-3 and caspase-8, but are devoid of mitochondrial regulators of apoptosis. Cell Death Differ 2001;8:1197-206.
30. Lang F, Gulbins E, Lang PA, Zappulla D, Foller M. Ceramide in suicidal death of erythrocytes. Cell Physiol Biochem 2010;26:21-8.
31. Klarl BA, Lang PA, Kempe DS, Niemoeller OM, Akel A, Sobiesiak M et al. Protein kinase C mediates erythrocyte "programmed cell death" following glucose depletion. Am J Physiol Cell Physiol 2006;290:C244-53.
32. Bhavsar SK, Bobbala D, Xuan NT, Foller M, Lang F. Stimulation of suicidal erythrocyte death by alpha-lipoic acid. Cell Physiol Biochem 2010;26:859-68.
33. Foller M, Huber SM, Lang F. Erythrocyte programmed cell death. IUBMB Life 2008;60:661-8.
34. Foller M, Mahmud H, Gu S, Wang K, Floride E, Kucherenko Y et al. Participation of leukotriene C(4) in the regulation of suicidal erythrocyte death. J Physiol Pharmacol 2009;60:135-43.
35. Lau IP, Chen H, Wang J, Ong HC, Leung KC, Ho HP et al. In vitro effect of CTAB- and PEG-coated gold nanorods on the induction of eryptosis/erythroptosis in human erythrocytes. Nanotoxicology 2012;6:847-56.
36. Maellaro E, Leoncini S, Moretti D, Del Bello B, Tanganelli I, De Felice C et al. Erythrocyte caspase-3 activation and oxidative imbalance in erythrocytes and in plasma of type 2 diabetic patients. Acta Diabetol 2013;50:489-95.
37. Foller M, Feil S, Ghoreschi K, Koka S, Gerling A, Thunemann M et al. Anemia and splenomegaly in cGKI-deficient mice. Proc Natl Acad Sci USA 2008;105:6771-6.
38. Bhavsar SK, Gu S, Bobbala D, Lang F. Janus kinase 3 is expressed in erythrocytes, phosphorylated upon energy depletion and involved in the regulation of suicidal erythrocyte death. Cell Physiol Biochem 2011;27:547-56.
39. Kucherenko Y, Zelenak C, Eberhard M, Qadri SM, Lang F. Effect of casein kinase 1alpha activator pyrvinium pamoate on erythrocyte ion channels. Cell Physiol Biochem 2012;30:407-17.
40. Zelenak C, Eberhard M, Jilani K, Qadri SM, Macek B, Lang F. Protein kinase CK1alpha regulates erythrocyte survival. Cell Physiol Biochem 2012;29:171-80.
41. Gatidis S, Zelenak C, Fajol A, Lang E, Jilani K, Michael D et al. p38 MAPK activation and function following osmotic shock of erythrocytes. Cell Physiol Biochem 2011;28:1279-86.
42. Zelenak C, Foller M, Velic A, Krug K, Qadri SM, Viollet B et al. Proteome analysis of erythrocytes lacking AMP-activated protein kinase reveals a role of PAK2 kinase in eryptosis. J Proteome Res 2011;10:1690-7.
43. Lupescu A, Shaik N, Jilani K, Zelenak C, Lang E, Pasham V et al. Enhanced Erythrocyte Membrane Exposure of Phosphatidylserine Following Sorafenib Treatment: an in vivo and in vitro Study. Cell Physiol Biochem 2012;30:876-88.
44. Shaik N, Lupescu A, Lang F. Sunitinib-sensitive suicidal erythrocyte death. Cell Physiol Biochem 2012;30:512-22.
45. Abed M, Towhid ST, Mia S, Pakladok T, Alesutan I, Borst O et al. Sphingomyelinase-induced adhesion of eryptotic erythrocytes to endothelial cells. Am J Physiol Cell Physiol 2012;303:C991-9.
46. Abed M, Towhid ST, Shaik N, Lang F. Stimulation of suicidal death of erythrocytes by rifampicin. Toxicology 2012;302:123-8.
47. Bottger E, Multhoff G, Kun JF, Esen M. Plasmodium falciparum-infected erythrocytes induce granzyme B by NK cells through expression of host-Hsp70. PLoS ONE 2012;7:e33774.
48. Felder KM, Hoelzle K, Ritzmann M, Kilchling T, Schiele D, Heinritzi K et al. Hemotrophic mycoplasmas induce programmed cell death in red blood cells. Cell Physiol Biochem 2011;27:557-64.
49. Firat U, Kaya S, Cim A, Buyukbayram H, Gokalp O, Dal MS et al. Increased caspase-3 immunoreactivity of erythrocytes in STZ diabetic rats. Exp Diabetes Res 2012;2012:316384.
50. Ganesan S, Chaurasiya ND, Sahu R, Walker LA, Tekwani BL. Understanding the mechanisms for metabolism-linked hemolytic toxicity of primaquine against glucose 6-phosphate dehydrogenase deficient human erythrocytes: evaluation of eryptotic pathway. Toxicology 2012;294:54-60.
51. Gao M, Cheung KL, Lau IP, Yu WS, Fung KP, Yu B et al. Polyphyllin D induces apoptosis in human erythrocytes through Ca(2)(+) rise and membrane permeabilization. Arch Toxicol 2012;86:741-52.
52. Ghashghaeinia M, Cluitmans JC, Akel A, Dreischer P, Toulany M, Koberle M et al. The impact of erythrocyte age on eryptosis. Br J Haematol 2012;157:606-14.
53. Ghashghaeinia M, Toulany M, Saki M, Bobbala D, Fehrenbacher B, Rupec R et al. The NFkB pathway inhibitors Bay 11-7082 and parthenolide induce programmed cell death in anucleated Erythrocytes. Cell Physiol Biochem 2011;27:45-54.
54. Jilani K, Lupescu A, Zbidah M, Abed M, Shaik N, Lang F. Enhanced apoptotic death of erythrocytes induced by the mycotoxin ochratoxin A. Kidney Blood Press Res 2012;36:107-18.
55. Jilani K, Lupescu A, Zbidah M, Shaik N, Lang F. Withaferin A-stimulated Ca(2+) entry, ceramide formation and suicidal death of erythrocytes. Toxicol In Vitro 2013;27:52-8.
56. Kucherenko YV, Lang F. Inhibitory effect of furosemide on non-selective voltage-independent cation channels in human erythrocytes. Cell Physiol Biochem 2012;30:863-75.
57. Lang E, Jilani K, Zelenak C, Pasham V, Bobbala D, Qadri SM et al. Stimulation of suicidal erythrocyte death by benzethonium. Cell Physiol Biochem 2011;28:347-54.
58. Lang E, Qadri SM, Jilani K, Zelenak C, Lupescu A, Schleicher E et al. Carbon monoxide-sensitive apoptotic death of erythrocytes. Basic Clin Pharmacol Toxicol 2012;111:348-55.
59. Lang F, Qadri SM. Mechanisms and significance of eryptosis, the suicidal death of erythrocytes. Blood Purif 2012;33:125-30.
60. Lupescu A, Jilani K, Zbidah M, Lang E, Lang F. Enhanced Ca(2+) entry, ceramide formation, and apoptotic death of erythrocytes triggered by plumbagin. J Nat Prod 2012;75:1956-61.
61. Lupescu A, Jilani K, Zbidah M, Lang F. Induction of apoptotic erythrocyte death by rotenone. Toxicology 2012;300:132-7.
62. Lupescu A, Jilani K, Zelenak C, Zbidah M, Qadri SM, Lang F. Hexavalent chromium-induced erythrocyte membrane phospholipid asymmetry. Biometals 2012;25:309-18.
63. Polak-Jonkisz D, Purzyc L. Ca influx versus efflux during eryptosis in uremic erythrocytes. Blood Purif 2012;34:209-10.
64. Qadri SM, Bauer J, Zelenak C, Mahmud H, Kucherenko Y, Lee SH et al. Sphingosine but not sphingosine-1-phosphate stimulates suicidal erythrocyte death. Cell Physiol Biochem 2011;28:339-46.
65. Qadri SM, Kucherenko Y, Lang F. Beauvericin induced erythrocyte cell membrane scrambling. Toxicology 2011;283:24-31.
66. Qadri SM, Kucherenko Y, Zelenak C, Jilani K, Lang E, Lang F. Dicoumarol activates Ca2+-permeable cation channels triggering erythrocyte cell membrane scrambling. Cell Physiol Biochem 2011;28:857-64.
67. Qian EW, Ge DT, Kong SK. Salidroside protects human erythrocytes against hydrogen peroxide-induced apoptosis. J Nat Prod 2012;75:531-7.
68. Shaik N, Zbidah M, Lang F. Inhibition of Ca(2+) entry and suicidal erythrocyte death by naringin. Cell Physiol Biochem 2012;30:678-86.
69. Vota DM, Maltaneri RE, Wenker SD, Nesse AB, Vittori DC. Differential erythropoietin action upon cells induced to eryptosis by different agents. Cell Biochem Biophys 2013;65:145-57.
70. Weiss E, Cytlak UM, Rees DC, Osei A, Gibson JS. Deoxygenation-induced and Ca(2+) dependent phosphatidylserine externalisation in red blood cells from normal individuals and sickle cell patients. Cell Calcium 2012;51:51-6.
71. Zappulla D. Environmental stress, erythrocyte dysfunctions, inflammation, and the metabolic syndrome: adaptations to CO2 increases? J Cardiometab Syndr 2008;3:30-4.
72. Zbidah M, Lupescu A, Jilani K, Lang F. Stimulation of suicidal erythrocyte death by fumagillin. Basic Clin Pharmacol Toxicol 2013;112:346-51.
73. Zbidah M, Lupescu A, Shaik N, Lang F. Gossypol-induced suicidal erythrocyte death. Toxicology 2012;302:101-5.
74. Zelenak C, Pasham V, Jilani K, Tripodi PM, Rosaclerio L, Pathare G et al. Tanshinone IIA stimulates erythrocyte phosphatidylserine exposure. Cell Physiol Biochem 2012;30:282-94.
75. Lang E, Qadri SM, Lang F. Killing me softly - suicidal erythrocyte death. Int J Biochem Cell Biol 2012;44:1236-43.
76. Calderon-Salinas JV, Munoz-Reyes EG, Guerrero-Romero JF, Rodriguez-Moran M, Bracho-Riquelme RL, Carrera-Gracia MA et al. Eryptosis and oxidative damage in type 2 diabetic mellitus patients with chronic kidney disease. Mol Cell Biochem 2011;357:171-9.
77. Nicolay JP, Schneider J, Niemoeller OM, Artunc F, Portero-Otin M, Haik G Jr et al. Stimulation of suicidal erythrocyte death by methylglyoxal. Cell Physiol Biochem 2006;18:223-32.
78. Myssina S, Huber SM, Birka C, Lang PA, Lang KS, Friedrich B et al. Inhibition of erythrocyte cation channels by erythropoietin. J Am Soc Nephrol 2003;14:2750-7.
79. Kempe DS, Akel A, Lang PA, Hermle T, Biswas R, Muresanu J et al. Suicidal erythrocyte death in sepsis. J Mol Med 2007;85:269-77.
80. Bobbala D, Alesutan I, Foller M, Huber SM, Lang F. Effect of anandamide in Plasmodium Berghei-infected mice. Cell Physiol Biochem 2010;26:355-62.
81. Foller M, Bobbala D, Koka S, Huber SM, Gulbins E, Lang F. Suicide for survival-death of infected erythrocytes as a host mechanism to survive malaria. Cell Physiol Biochem 2009;24:133-40.
82. Koka S, Bobbala D, Lang C, Boini KM, Huber SM, Lang F. Influence of paclitaxel on parasitemia and survival of Plasmodium berghei infected mice. Cell Physiol Biochem 2009;23:191-8.
83. Lang PA, Schenck M, Nicolay JP, Becker JU, Kempe DS, Lupescu A et al. Liver cell death and anemia in Wilson disease involve acid sphingomyelinase and ceramide. Nat Med 2007;13:164-70.
84. Siraskar B, Ballal A, Bobbala D, Foller M, Lang F. Effect of amphotericin B on parasitemia and survival of plasmodium berghei-infected mice. Cell Physiol Biochem 2010;26:347-54.
85. Lang PA, Kasinathan RS, Brand VB, Duranton C, Lang C, Koka S et al. Accelerated clearance of Plasmodium-infected erythrocytes in sickle cell trait and annexin-A7 deficiency. Cell Physiol Biochem 2009;24:415-28.
86. Kempe DS, Lang PA, Duranton C, Akel A, Lang KS, Huber SM et al. Enhanced programmed cell death of iron-deficient erythrocytes. FASEB J 2006;20:368-70.
87. Qadri SM, Mahmud H, Lang E, Gu S, Bobbala D, Zelenak C et al. Enhanced suicidal erythrocyte death in mice carrying a loss-of-function mutation of the adenomatous polyposis coli gene. J Cell Mol Med 2012;16:1085-93.
88. Birka C, Lang PA, Kempe DS, Hoefling L, Tanneur V, Duranton C et al. Enhanced susceptibility to erythrocyte "apoptosis" following phosphate depletion. Pflugers Arch 2004;448:471-7.
89. Munoz-de-Rueda P, Ruiz-Extremera A, Candel JM, Quiles R, Martin AB, Diago M et al. Plasma ribavirin trough concentrations during treatment of chronic hepatitis C in genotype-1 patients. J Clin Gastroenterol 2012;46:328-33.
90. Bookchin RM, Ortiz OE, Lew VL. Activation of calcium-dependent potassium channels in deoxygenated sickled red cells. Prog Clin Biol Res 1987;240:193-200.
91. Brand VB, Sandu CD, Duranton C, Tanneur V, Lang KS, Huber SM et al. Dependence of Plasmodium falciparum in vitro growth on the cation permeability of the human host erythrocyte. Cell Physiol Biochem 2003;13:347-56.
92. Harrison HE, Bunting H, Ordway NK, Albrink WS. The Pathogenesis of the Renal Injury Produced in the Dog by Hemoglobin or Methemoglobin. J Exp Med 1947;86:339-56.
93. Borst O, Abed M, Alesutan I, Towhid ST, Qadri SM, Foller M et al. Dynamic adhesion of eryptotic erythrocytes to endothelial cells via CXCL16/SR-PSOX. Am J Physiol Cell Physiol 2012;302:C644-51.
94. Andrews DA, Low PS. Role of red blood cells in thrombosis. Curr Opin Hematol 1999;6:76-82.
95. Closse C, Dachary-Prigent J, Boisseau MR. Phosphatidylserine-related adhesion of human erythrocytes to vascular endothelium. Br J Haematol 1999;107:300-2.
96. Gallagher PG, Chang SH, Rettig MP, Neely JE, Hillery CA, Smith BD et al. Altered erythrocyte endothelial adherence and membrane phospholipid asymmetry in hereditary hydrocytosis. Blood 2003;101:4625-7.
97. Pandolfi A, Di Pietro N, Sirolli V, Giardinelli A, Di Silvestre S, Amoroso L et al. Mechanisms of uremic erythrocyte-induced adhesion of human monocytes to cultured endothelial cells. J Cell Physiol 2007;213:699-709.
98. Wood BL, Gibson DF, Tait JF. Increased erythrocyte phosphatidylserine exposure in sickle cell disease: flow-cytometric measurement and clinical associations. Blood 1996;88:1873-80.
99. Chung SM, Bae ON, Lim KM, Noh JY, Lee MY, Jung YS et al. Lysophosphatidic acid induces thrombogenic activity through phosphatidylserine exposure and procoagulant microvesicle generation in human erythrocytes. Arterioscler Thromb Vasc Biol 2007;27:414-21.
100. Zwaal RF, Comfurius P, Bevers EM. Surface exposure of phosphatidylserine in pathological cells. Cell Mol Life Sci 2005;62:971-88.